TD Asset Management
REGN icon

TD Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$169M Sell
322,857
-29,030
-8% -$15.2M 0.14% 143
2025
Q1
$223M Sell
351,887
-7,502
-2% -$4.76M 0.21% 100
2024
Q4
$256M Buy
359,389
+29,322
+9% +$20.9M 0.23% 90
2024
Q3
$344M Sell
330,067
-21,478
-6% -$22.4M 0.3% 68
2024
Q2
$369M Buy
351,545
+82,034
+30% +$86.2M 0.34% 59
2024
Q1
$259M Buy
269,511
+166,998
+163% +$161M 0.24% 95
2023
Q4
$90M Sell
102,513
-77,754
-43% -$68.3M 0.09% 199
2023
Q3
$148M Buy
180,267
+70,628
+64% +$58.1M 0.18% 105
2023
Q2
$78.8M Sell
109,639
-2,495
-2% -$1.79M 0.09% 174
2023
Q1
$92.1M Buy
112,134
+9,469
+9% +$7.78M 0.11% 158
2022
Q4
$74.1M Buy
102,665
+10,323
+11% +$7.45M 0.09% 179
2022
Q3
$63.9M Buy
92,342
+5,048
+6% +$3.49M 0.08% 194
2022
Q2
$51.6M Buy
87,294
+5,855
+7% +$3.46M 0.06% 252
2022
Q1
$56.9M Sell
81,439
-203
-0.2% -$142K 0.05% 268
2021
Q4
$51.6M Buy
81,642
+1,634
+2% +$1.03M 0.04% 324
2021
Q3
$48.4M Sell
80,008
-780
-1% -$472K 0.05% 291
2021
Q2
$46.4M Buy
80,788
+2,104
+3% +$1.21M 0.05% 306
2021
Q1
$37.2M Buy
78,684
+2,826
+4% +$1.34M 0.04% 333
2020
Q4
$36.6M Buy
75,858
+1,146
+2% +$554K 0.04% 315
2020
Q3
$41.8M Buy
74,712
+5,258
+8% +$2.94M 0.06% 249
2020
Q2
$43.3M Buy
69,454
+8,290
+14% +$5.17M 0.06% 224
2020
Q1
$29.9M Buy
61,164
+8,665
+17% +$4.23M 0.05% 257
2019
Q4
$19.7M Sell
52,499
-5,867
-10% -$2.2M 0.03% 392
2019
Q3
$16.2M Buy
58,366
+1,655
+3% +$459K 0.02% 405
2019
Q2
$17.8M Sell
56,711
-10,910
-16% -$3.41M 0.03% 398
2019
Q1
$27.8M Buy
67,621
+19,567
+41% +$8.03M 0.04% 310
2018
Q4
$17.9M Buy
48,054
+2,299
+5% +$859K 0.03% 369
2018
Q3
$18.5M Sell
45,755
-3,988
-8% -$1.61M 0.03% 403
2018
Q2
$17.2M Buy
49,743
+1,634
+3% +$564K 0.03% 406
2018
Q1
$16.6M Sell
48,109
-385
-0.8% -$133K 0.03% 421
2017
Q4
$18.2M Sell
48,494
-153
-0.3% -$57.5K 0.03% 404
2017
Q3
$21.8M Sell
48,647
-3,577
-7% -$1.6M 0.03% 371
2017
Q2
$25.6M Sell
52,224
-11,989
-19% -$5.89M 0.04% 337
2017
Q1
$24.9M Sell
64,213
-405
-0.6% -$157K 0.04% 348
2016
Q4
$23.7M Sell
64,618
-3,226
-5% -$1.18M 0.04% 329
2016
Q3
$27.3M Sell
67,844
-18,479
-21% -$7.43M 0.05% 296
2016
Q2
$30.1M Sell
86,323
-11,011
-11% -$3.85M 0.05% 266
2016
Q1
$35.1M Sell
97,334
-16,631
-15% -$5.99M 0.07% 237
2015
Q4
$61.9M Buy
113,965
+3,348
+3% +$1.82M 0.12% 148
2015
Q3
$51.5M Buy
110,617
+11,800
+12% +$5.49M 0.1% 169
2015
Q2
$50.4M Buy
98,817
+12,227
+14% +$6.24M 0.09% 178
2015
Q1
$39.1M Buy
86,590
+305
+0.4% +$138K 0.07% 219
2014
Q4
$35.4M Buy
86,285
+5,430
+7% +$2.23M 0.06% 227
2014
Q3
$29.2M Buy
80,855
+4,865
+6% +$1.75M 0.05% 257
2014
Q2
$21.5M Sell
75,990
-26,610
-26% -$7.52M 0.04% 317
2014
Q1
$30.8M Sell
102,600
-16,100
-14% -$4.83M 0.06% 230
2013
Q4
$32.7M Sell
118,700
-2,300
-2% -$633K 0.06% 209
2013
Q3
$37.9M Sell
121,000
-4,300
-3% -$1.35M 0.08% 184
2013
Q2
$28.2M Buy
+125,300
New +$28.2M 0.06% 210